Sotagliflozin Surpasses Dapagliflozin in Mitigating Salt-Sensitive Hypertension and Renal Damage in Rat Models
Houston, TX (November 7, 2025) — Sodium-glucose co-transporter 2 (SGLT2) inhibitors have long been recognized for their role in managing ...
